| 08:30-09:15 | Case Report |
Airway management of upper tracheal tumors |
|
||||
| 09:15-10:00 | Case Report |
A rare complication during neurosurgery |
|
||||
| 10:00-10:45 | Case Report |
One clinical case of acute hypoxemia during the operation |
|
||||
| 10:45-11:30 | Case Report |
A case of "silent lung" during the perioperative period of craniopharyngioma |
|
||||
| 12:15-12:20 | Speech |
Speech |
|
||||
| 12:20-12:45 | Symposium |
Progress in clinical use of visual endobronchial blocker |
|
||||
| 12:45-13:10 | Symposium |
Application of visual endobronchial blocker during one-lung ventilation surgery in children |
|
||||
| 13:10-13:15 | Discuss |
Discuss |
|||||
| 13:30-13:50 | Featured Presentation |
Perioperative Fasting and Cancer: Mechanisms and Clinical Applications |
|
||||
| 13:50-14:10 | Featured Presentation |
Stress: From neural to immune system |
|
||||
| 14:30-14:50 | Featured Presentation |
Molecular mechanism of multi-disciplinary network regulation of perioperative stress and lung injury |
|
||||
| 14:50-15:00 | Oral Presentation |
Notch1 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma through OXCT1-Mediated Succinate-Histone H3K79 Succinylation Axis |
|
||||
| 15:00-15:15 | Discuss |
Discuss |
|||||
| 15:15-15:35 | Featured Presentation |
GABAergic signal and Tumorigensis |
|
||||
| 15:35-15:55 | Featured Presentation |
Hemodynamic monitoring based on artificial intelligence |
|
||||
| 15:55-16:15 | Featured Presentation |
The Prevention and Treatment of Postoperative Delirium in Cancer Patients |
|
||||
| 16:15-16:25 | Oral Presentation |
Impact of postoperative depression and immune-inflammatory biomarkers on the prognosis of patients with esophageal cancer receiving minimally invasive esophagectomy: a retrospective cohort study based on a Chinese population |
|
||||
| 16:25-16:35 | Oral Presentation |
Preliminary Exploration of Gender Differences-Related Risk Factors in Patients with Pulmonary Nodules: A Small-Sample Binary Logistic Regression Analysis |
|
||||
| 16:35-17:00 | Discuss |
Discuss |
|||||